Pershing Square Announces New Position in Valeant Pharmaceuticals International

AMSTERDAM--(BUSINESS WIRE)-- Regulatory News:

Pershing Square Holdings, Ltd. (ticker: PSH:NA) announced today a new position in Valeant Pharmaceuticals International, Inc. (ticker: NYSE: VRX) representing approximately 16.9% of the PSH portfolio (based on the closing NAV of PSH and the closing share price of VRX on Friday, 6 March 2015).

Pershing Square Capital Management, L.P., the investment manager for Pershing Square Holdings, Ltd., announced that various funds it manages have purchased 16,473,933 shares of Valeant Pharmaceuticals International, Inc., representing 4.9% of Valeant.

About Pershing Square Holdings, Ltd.

Pershing Square Holdings, Ltd. is a concentrated, research‐intensive, fundamental value investor in the public markets.

MEDIA CONTACTS
StockWell Communications
Tim Burt, +44 (0)20 7240 2486
[email protected]

Source: Pershing Square Holdings, Ltd.

You May Also Be Interested In

• Gridko to Showcase Roll-Off Trailer Lineup at NATDA Trailer Show 2026
• Ibotta to Participate in Upcoming Investor Conferences
• Onco360® Has Been Selected as a National Pharmacy Partner for RASONQUE™ (daraxonrasib)